Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sumilab is a Mexican company based in Culiacán, Sinaloa that specializes in the production and distribution of chemical substances, equipment, and materials for laboratories. It has supplied reagents, filters, laboratory accessories, ovens, microscopes, and other scientific materials primarily to government hospitals and educational institutions in Sinaloa. In May 2023 it was sanctioned by the U.S. Treasury Department’s Office of Foreign Assets Control due to alleged links with the Sinaloa Cartel—specifically for supplying chemical precursors used in illicit drug manufacturing—which effectively blocks its assets under U.S. jurisdiction and prohibits transactions with U.S. entities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sumilab.